TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
TRIV was delisted on the 3rd of February, 2016.
38 hedge funds and large institutions have $149M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 4 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 41 → 38 (-3)
12% less capital invested
Capital invested by funds: $169M → $149M (-$20.1M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.62M |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$3.62M |
| 3 |
Morgan Stanley
New York
|
+$220K |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$137K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$116K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$1.72M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.63M |
| 3 |
DM
Deerfield Management
New York
|
-$1.63M |
| 4 |
JP Morgan Chase
New York
|
-$1.5M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$961K |
TRIV Hedge Fund Activity: Q1 2015 in Review
38 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q1 2015, worth a combined $149M — down 12% from $169M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TRIV and 1 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 12 added.
The largest buyer was Fidelity Investments, adding an estimated $4.62M. The largest seller was Redmile Group, cutting an estimated $1.72M.
- 38 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q1 2015, down from 41 in Q4 2014.
- Funds reported $149M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q1 2015, down 12% quarter-over-quarter.
- 1 fund opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q1 2015 and 4 closed out, a net change of -3 holders.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q1 2015 was Fidelity Investments, an estimated $4.62M added.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK seller in Q1 2015 was Redmile Group, an estimated $1.72M sold.
Based on aggregated 13F filings for Q1 2015.